Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer
Leukemia, Published online: 18 April 2024; doi:10.1038/s41375-024-02253-3Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer (Source: Leukemia)
Source: Leukemia - April 18, 2024 Category: Hematology Authors: Christopher Maximilian Arends Klara Kopp Raphael Hablesreiter Natalia Estrada Friederike Christen Ute Martha Moll Robert Zeillinger Wolfgang Daniel Schmitt Jalid Sehouli Hagen Kulbe Maximilian Fleischmann Isabelle Ray-Coquard Alain Zeimet Francesco Raspag Source Type: research
KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia
Leukemia, Published online: 18 April 2024; doi:10.1038/s41375-024-02244-4KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia (Source: Leukemia)
Source: Leukemia - April 18, 2024 Category: Hematology Authors: Shinju Iyoda Kenichi Yoshida Kota Shoji Nana Ito Miu Tanaka Yasuhito Nannya Genki Yamato Shinichi Tsujimoto Norio Shiba Yasuhide Hayashi Yusuke Shiozawa Yuichi Shiraishi Kenichi Chiba Ai Okada Hiroko Tanaka Satoru Miyano Yuhki Koga Hiroaki Goto Hiroshi Mo Source Type: research
Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation
Leukemia, Published online: 17 April 2024; doi:10.1038/s41375-024-02251-5Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation (Source: Leukemia)
Source: Leukemia - April 17, 2024 Category: Hematology Authors: Wenyi Lu Hairong Lyu Xia Xiao Xue Bai Meng Zhang Jiaxi Wang Yedi Pu Juanxia Meng Xiaomei Zhang Haibo Zhu Ting Yuan Bing Wang Xin Jin Xinping Cao Zhao Wang Tianle Xie Haotian Meng Alexey V. Stepanov Alexander G. Gabibov Yuxin An Rui Sun Yu Zhang Mikhail A. Source Type: research
Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms
Leukemia, Published online: 17 April 2024; doi:10.1038/s41375-024-02249-zMutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms (Source: Leukemia)
Source: Leukemia - April 17, 2024 Category: Hematology Authors: Susann Winter Marie Schneider Uta Oelschlaegel Giulia Maggioni Elena Riva Marco Gabriele Raddi Sara Bencini Benedetta Peruzzi Desmond Choy Rita Antunes Dos Reis Esther G üse Christopher Lischer Julio Vera Jessica A. Timms Nicolas Sompairac Katja Sockel A Source Type: research
Autophagy degrades immunogenic endogenous retroelements induced by 5-azacytidine in acute myeloid leukemia
Leukemia, Published online: 16 April 2024; doi:10.1038/s41375-024-02250-6Autophagy degrades immunogenic endogenous retroelements induced by 5-azacytidine in acute myeloid leukemia (Source: Leukemia)
Source: Leukemia - April 16, 2024 Category: Hematology Authors: Nandita Noronha Chantal Durette Maxime Cahuzac Bianca E Silva Justine Courtois Juliette Humeau Allan Sauvat Marie-Pierre Hardy Krystel Vincent Jean-Philippe Laverdure Jo ël Lanoix Fr édéric Baron Pierre Thibault Claude Perreault Gregory Ehx Source Type: research
Correction to: Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors
Leukemia, Published online: 15 April 2024; doi:10.1038/s41375-024-02185-yCorrection to: Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors (Source: Leukemia)
Source: Leukemia - April 15, 2024 Category: Hematology Authors: Jooeun Bae Teru Hideshima Yu-Tzu Tai Yan Song Paul Richardson Noopur Raje Nikhil C. Munshi Kenneth C. Anderson Source Type: research
Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations
Leukemia, Published online: 13 April 2024; doi:10.1038/s41375-024-02248-0Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations (Source: Leukemia)
Source: Leukemia - April 13, 2024 Category: Hematology Authors: Nikola Curik Adam Laznicka Vaclava Polivkova Jitka Krizkova Eva Pokorna Pavel Semerak Pavla Suchankova Pavel Burda Andreas Hochhaus Katerina Machova Polakova Source Type: research
Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma
Leukemia, Published online: 12 April 2024; doi:10.1038/s41375-024-02237-3Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma (Source: Leukemia)
Source: Leukemia - April 12, 2024 Category: Hematology Authors: Jian Cui Yuntong Liu Rui Lv Wenqiang Yan Jingyu Xu Lingna Li Chenxing Du Tengteng Yu Shuaishuai Zhang Shuhui Deng Weiwei Sui Mu Hao Shuhua Yi Dehui Zou Lugui Qiu Yan Xu Gang An Source Type: research
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression
Leukemia, Published online: 12 April 2024; doi:10.1038/s41375-024-02245-3Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression (Source: Leukemia)
Source: Leukemia - April 12, 2024 Category: Hematology Authors: Shinichiro Matsui Chihiro Ri Lyndsey C. Bolanos Kwangmin Choi Asuka Shibamiya Arata Ishii Koji Takaishi Nagisa Oshima-Hasegawa Shokichi Tsukamoto Yusuke Takeda Naoya Mimura Akihide Yoshimi Koutaro Yokote Daniel T. Starczynowski Emiko Sakaida Tomoya Muto Source Type: research
Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia
Leukemia, Published online: 10 April 2024; doi:10.1038/s41375-024-02241-7Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia (Source: Leukemia)
Source: Leukemia - April 10, 2024 Category: Hematology Authors: Hayden L. Bell Helen J. Blair Samantha J. Jepson Gosling Martin Galler Daniel Astley Anthony V. Moorman Olaf Heidenreich Gareth J. Veal Frederik W. van Delft John Lunec Julie A. E. Irving Source Type: research
Management of isocitrate dehydrogenase 1/2 mutated acute myeloid leukemia
Leukemia, Published online: 10 April 2024; doi:10.1038/s41375-024-02246-2Management of isocitrate dehydrogenase 1/2 mutated acute myeloid leukemia (Source: Leukemia)
Source: Leukemia - April 10, 2024 Category: Hematology Authors: Harry Fruchtman Zachary M. Avigan Julian A. Waksal Nicole Brennan John O. Mascarenhas Source Type: research
Genome-wide DNA methylation-analysis of blastic plasmacytoid dendritic cell neoplasm identifies distinct molecular features
Leukemia, Published online: 10 April 2024; doi:10.1038/s41375-024-02240-8Genome-wide DNA methylation-analysis of blastic plasmacytoid dendritic cell neoplasm identifies distinct molecular features (Source: Leukemia)
Source: Leukemia - April 10, 2024 Category: Hematology Authors: Axel K ünstner Julian Schwarting Hanno M. Witte Pengwei Xing Veronica Bernard Stephanie St ölting Philipp Lohneis Florian Janke Maede Salehi Xingqi Chen Kathrin Kusch Holger S ültmann Emil Chteinberg Anja Fischer Reiner Siebert Nikolas von Bubnoff Hart Source Type: research
Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures
Leukemia, Published online: 09 April 2024; doi:10.1038/s41375-024-02243-5Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures (Source: Leukemia)
Source: Leukemia - April 9, 2024 Category: Hematology Authors: Saurabh Zanwar Morie A. Gertz Eli Muchtar Francis K. Buadi Taxiarchis Kourelis Wilson Gonsalves Ronald S. Go Suzanne Hayman Prashant Kapoor Moritz Binder Joselle Cook David Dingli Nelson Leung Yi Lin Rahma Warsame Amie Fonder Miriam Hobbs Yi Lisa Hwa Robe Source Type: research
Pre-frailty after blood or marrow transplantation and the risk of subsequent mortality
Leukemia, Published online: 05 April 2024; doi:10.1038/s41375-024-02238-2Pre-frailty after blood or marrow transplantation and the risk of subsequent mortality (Source: Leukemia)
Source: Leukemia - April 5, 2024 Category: Hematology Authors: Nora Balas Joshua S. Richman Wendy Landier Sadeep Shrestha Katia J. Bruxvoort Lindsey Hageman Qingrui Meng Elizabeth Ross Alysia Bosworth F. Lennie Wong Ravi Bhatia Stephen J. Forman Saro H. Armenian Daniel J. Weisdorf Smita Bhatia Source Type: research
Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasms
Leukemia, Published online: 04 April 2024; doi:10.1038/s41375-024-02234-6Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasms (Source: Leukemia)
Source: Leukemia - April 4, 2024 Category: Hematology Authors: Charles Dussiau Thibault Comont Camille Knosp In ès Vergnolle Clotilde Bravetti Alban Canali Amandine Houvert Laetitia Largeaud Christian Daveaux Laila Zaroili Chlo é Friedrich Isma ël Boussaid Loria Zalmai Carole Almire Odile Rauzy Lise Willems Rudy B Source Type: research
